Webb10 apr. 2024 · Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. About the company Risk Analysis Earnings have declined by 8.5% per year over past 5 years Has less than 1 year of cash runway Makes less than USD$1m in revenue ($0) Does not have a meaningful market cap ($7M) + 2 more risks See All Risk Checks … WebbPhio Pharmaceuticals Corp (PHIO) Stock Price Today, News, Quotes, FAQs and Fundamentals 8.50% KRYS 4.70% INFY 0.46% FAST 0.66% UNL 3.55% More …
Phio Pharmaceuticals Initiates In Vivo Studies of INTASYL Based ...
Webb13 apr. 2024 · Phio Pharmaceuticals Corporation Aktie ISIN: US71880W4024 · WKN: A3D451 · SYM: PHIO 5,710 USD -1,21 % -0,070 USD Letzter Kurs 06.04.23 · NYSE 5,440 USD 100 STK Geldkurs 06.04.23 6,000 USD 100... WebbPHIO / Phio Pharmaceuticals Corp - Net Long/Short Value This page provides the net long/short valuations for each institutional holding reported via 13F or NPORT filings. To … how big is a 20 x 40 tent
Why did Phio Pharmaceuticals stock go up today? - MarketBeat
WebbPHIO - Phio Pharmaceuticals Corp. Stock Price and Quote TIP: Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. × publish chart save to portfolio create alert compare perf. Candle - advanced Intraday Daily Weekly Monthly Draw Fullscreen Settings PHIO - Stock Price Chart PHIO [NASD] WebbAt Phio Pharmaceuticals, our mission is to develop innovative cancer treatments that overcome tumor immunosuppression and weaponize the immune system against … Webb12 apr. 2024 · Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics. The company was founded on … how big is a 23 week old baby